MedPath

Lonoctocog alfa

Generic Name
Lonoctocog alfa
Brand Names
Afstyla
Drug Type
Biotech
CAS Number
1388129-63-2
Unique Ingredient Identifier
VQ723R7O8R

Overview

No overview information available.

Background

No background information available.

Indication

For the treatment of hemophilia A, von Willebrand disease and Factor XIII deficiency.

Associated Conditions

  • Bleeding

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Approved Products

Product Name
Manufacturer
Route
Strength
Approved
NDC Code

No FDA products found

No FDA products found for this drug

EMA Approved Products

Medicine Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision
EMEA/H/C/004075
Germany
N/A
Authorised
2017/01/04
2016/11/10
11

HSA Approved Products

Product Name
Manufacturer
Dosage Form
Strength
Approved
Approval No.
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
500IU/vial
2019/09/27
SIN15822P
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
250IU/Vial
2019/09/27
SIN15821P
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
2000IU/vial
2019/09/27
SIN15824P
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
1000IU/vial
2019/09/27
SIN15823P
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
3000IU/vial
2019/09/27
SIN15820P

NMPA Approved Products

Product Name
Approval No.
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import

No NMPA products found

No NMPA products found for this drug

PPB Approved Products

Product Name
Registration Code
Company
Category
Sale Type
Reg. Date

No PPB products found

No PPB products found for this drug

© Copyright 2025. All Rights Reserved by MedPath